US Senate IVF bill fails after Republicans block it, despite Trump support
Updates throughout with results of the vote
By Moira Warburton
WASHINGTON, Sept 17 (Reuters) -A U.S. Senate bill aimed at enshrining federal protections and expanding insurance coverage for fertility treatments failed on Tuesday, as Republicans voted against it days after Donald Trump surprised supporters by voicing support for such a policy.
The bill failed 51-44, falling short of the required 60-vote threshold after most Republicans voted against it for the second time. Democrats control the chamber by a slim 51-49 margin.
The bill's sponsor, Democratic Senator Tammy Duckworth, first attempted to get a vote on the same bill in late February, after the Alabama Supreme Court ruled the embryos used in in vitro fertilization, or IVF, should be considered children, jeopardizing access to the treatment used by millions of Americans every year.
"The freedom to get reproductive care is at risk for millions of other women whose most desperate hope in the world is to have a little one of their own," Duckworth, who had her two daughters via fertility treatments, said in a Senate floor speech after Tuesday's vote. "Republicans only seem to care about protecting life when it supposedly consists of some cells in a medical lab freezer."
Republican presidential candidate Trump said in August he would require the government or insurance companies to pay for IVF if he is elected, surprising some hardline Republicans for whom the treatment is controversial.
"We want to produce babies in this country, right?" Trump said during a town hall-style campaign event in La Crosse, Wisconsin.
Trump's campaign did not immediately respond to a request for comment on Tuesday.
Reporting by Moira Warburton in Washington; editing by Jonathan Oatis
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
